Active Ingredient: NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
Proprietary Name: SUMATRIPTAN AND NAPROXEN SODIUM
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 500MG;EQ 85MG BASE
Reference Listed Drug: No
Reference Standard: No
TE Code: AB
Application Number: A207457
Product Number: 001
Approval Date: Feb 15, 2018
Applicant Holder Full Name: AUROBINDO PHARMA LTD
Marketing Status:
Prescription
Patent and Exclusivity Information